These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 13886730)
1. Triparanol and nicotinic acid in the management of hypercholesterolaemia. DOAK PB; NICHOLSON GI; NORTH JD Australas Ann Med; 1962 Feb; 11():29-33. PubMed ID: 13886730 [No Abstract] [Full Text] [Related]
2. Triparanol therapy in coronary heart disease. A preliminary report. DAVIS FW Md State Med J; 1962 Apr; 11():178-81. PubMed ID: 13883898 [No Abstract] [Full Text] [Related]
3. The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease. HOLLANDER W; CHOBANIAN AV; WILKINS RW Prog Cardiovasc Dis; 1960 May; 2():637-44. PubMed ID: 13852510 [No Abstract] [Full Text] [Related]
4. Coronary atherosclerosis status of MER-29 (triparanol). CORCORAN AC Am Heart J; 1961 Apr; 61():431-5. PubMed ID: 13695464 [No Abstract] [Full Text] [Related]
5. A clinical study of triparanol (MER-29). LISAN P; OAKS W; MOYER JH Am J Cardiol; 1960 Aug; 6():246-51. PubMed ID: 14417444 [No Abstract] [Full Text] [Related]
7. CUTANEOUS EFFECTS OF HYPOCHOLESTEREMIC AGENTS. ROE DA N Y State J Med; 1964 Oct; 64():2559-63. PubMed ID: 14224225 [No Abstract] [Full Text] [Related]
8. The effects of sitosterol, nicotinic acid and triparanol on fat tolerance. Berkowitz D; Croll MW; Likoff W Am J Clin Nutr; 1962 Feb; 10():107-10. PubMed ID: 13867897 [No Abstract] [Full Text] [Related]
10. CORONARY ARTERY DISEASE WITH SPECIAL REFERENCE TO THE EFFECTS OF CHOLESTEROL-LOWERING AGENTS. HERRMANN GR Med Bull (Ann Arbor); 1964; 30():12-8. PubMed ID: 14170885 [No Abstract] [Full Text] [Related]
11. Note on MER-29 in arteriosclerotic heart disease. CORCORAN AC; ZIMMERMAN HA; CUTURELLI R Prog Cardiovasc Dis; 1960 May; 2():576-7. PubMed ID: 13811921 [No Abstract] [Full Text] [Related]
12. MANAGEMENT OF HYPERCHOLESTEROLEMIA. BLANKENHORN DH; CHIN HP GP; 1964 Apr; 29():135-42. PubMed ID: 14137557 [No Abstract] [Full Text] [Related]
13. THE INTERRELATIONS BETWEEN CHOLESTEROL AND OTHER LIPIDS. II. A REVIEW. MOSELEY V J S C Med Assoc; 1964 Jan; 60():10-7. PubMed ID: 14113153 [No Abstract] [Full Text] [Related]
15. [Nicotinic acid treatment in hypercholesterolemia and atheromatosis]. LJUNGGREN H; GRISSLER J; PROBST F Sven Lakartidn; 1961 Mar; 58():653-8. PubMed ID: 13762874 [No Abstract] [Full Text] [Related]
16. [Long-term treatment of hypercholesterolemia with nicotinic acid]. KLOSTER JH Ugeskr Laeger; 1961 Aug; 123():1169-71. PubMed ID: 13756953 [No Abstract] [Full Text] [Related]
17. Hypercholesterolemia. Use of niacin and niacin combinations in therapy. RIVIN AU Calif Med; 1962 Apr; 96(4):267-9. PubMed ID: 14492608 [TBL] [Abstract][Full Text] [Related]
18. Treatment of hypercholesteremia by nicotinic acid. Progress report with review of studies regarding mechanism of action. PARSONS WB Arch Intern Med; 1961 May; 107():639-52. PubMed ID: 13733028 [No Abstract] [Full Text] [Related]
19. MER-29 (triparanol) in the control of hypercholesterolaemia. JEPSON EM Proc R Soc Med; 1962 Jun; 55(6):480-4. PubMed ID: 14451692 [No Abstract] [Full Text] [Related]
20. Studies of serum desmosterol levels in hypercholesteremic subjects treated with triparanol (MER-29). Sachs BA; Wolfman L Am J Clin Nutr; 1961; 9():760-3. PubMed ID: 14495832 [No Abstract] [Full Text] [Related] [Next] [New Search]